Icono govco
 

Publicación:
Biotechnology, beginning with recombinant DNA toward a personalized medicine

Vista sencilla de ítem
dc.contributor.authorVerjan García, Noelspa
dc.date.accessioned2009-01-01T00:00:00Z
dc.date.accessioned2024-07-25T18:13:54Z
dc.date.available2009-01-01T00:00:00Z
dc.date.available2024-07-25T18:13:54Z
dc.date.issued2009-01-01
dc.description.abstractI would like to initiate this document by making a brief description of the term Biotechnology, hoping to not hurt the feelings of many other professionals better versed than I, on the details of this science, as the application of traditional and/or scientific knowledge to manipulate microorganisms, cells or even higher organisms, directed to supply goods and services to the daily growing human population. With almost 30-year-old, biotechnology, driven by the ability to transplant a gene from one organism into another to introduce novel functionality in the receiving organism, has evolved to repro- gram cellular behavior or incorporate increasingly com- plex biosynthetic pathways (to produce novel metabolic products or to achieve greater system integration) or genetic regulatory constructs (to modulate the activity of recombinant genes in space and time) (Bhalerao, 2009). Biotechnology one of the riskiest industries has achieved a dynamic growth and unparalleled discovery, outstanding advances and contributions to human and animal medicine. This has mainly been possible throughout the exploration of diverse unicellular and multicellular genomes, the genes and the proteins they encode, and together with the development of dozens of technologies, reach every day a better understand- ing of cell biology, homeostasis and disease. Thus, biotechnology has established as an industry, where any bio-product can be patentable.spa
dc.format.mimetypeapplication/mswordspa
dc.format.mimetypeapplication/pdfspa
dc.format.mimetypetext/htmlspa
dc.identifier.doi10.22579/20112629.237
dc.identifier.eissn2011-2629
dc.identifier.issn0121-3709
dc.identifier.urihttps://repositorio.unillanos.edu.co/handle/001/3757
dc.identifier.urlhttps://doi.org/10.22579/20112629.237
dc.language.isospaspa
dc.publisherUniversidad de los Llanosspa
dc.relation.bitstreamhttps://orinoquia.unillanos.edu.co/index.php/orinoquia/article/download/237/442
dc.relation.bitstreamhttps://orinoquia.unillanos.edu.co/index.php/orinoquia/article/download/237/673
dc.relation.bitstreamhttps://orinoquia.unillanos.edu.co/index.php/orinoquia/article/download/237/672
dc.relation.citationendpage74
dc.relation.citationissue1spa
dc.relation.citationstartpage69
dc.relation.citationvolume13spa
dc.relation.ispartofjournalOrinoquiaspa
dc.rightsOrinoquia - 2014spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://orinoquia.unillanos.edu.co/index.php/orinoquia/article/view/237spa
dc.titleBiotechnology, beginning with recombinant DNA toward a personalized medicinespa
dc.title.translatedBiotechnology, beginning with recombinant DNA toward a personalized medicineeng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublicationspa

Archivos

Colecciones

Revista Orinoquia